Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Abstract

Rifaximin significantly improved cognition and reduced endotoxin activity without significantly affecting the composition of the gut microbiome in patients with decompensated cirrhosis.